After the fasting, the uncomfortable cleanse and a drowsy ride home, it's a relief to have your colonoscopy screening behind ...

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median ...

“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the root of who’s at risk, we’ll know whom to screen, and ideally, find people ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...

RXRX Stock jumps after JPMorgan upgrade and trial data boost, fueling investor optimism in Recursion’s AI drug discovery ...

SALT LAKE CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a clinical-stage TechBio company decoding biology to radically improve lives, today announced positive Phase 1b/2 data from ...

Cancer. That medical condition that anybody who is sick and goes to the hospital to see a doctor, will not want to hear the doctor pronounce that he or she has been diagnosed with it. Just hearing ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity ...

EXERCISE has long been celebrated as one of the most effective ways to prevent cancer and promote overall health. Regular physical activity is consistently linked to lower cancer rates across multiple ...